28 results
FWP
ATOS
Atossa Therapeutics Inc
16 May 18
Free writing prospectus
2:39pm
Genetics Inc. (NASDAQ: ATOS) Our Mission: Develop novel pharmaceuticals and delivery systems to treat breast cancer and other breast conditions Debt … Issuer: Atossa Genetics Inc. (NASDAQ: ATOS) Our Mission: Develop novel pharmaceuticals and delivery systems to treat breast cancer and other breast
CORRESP
ATOS
Atossa Therapeutics Inc
3 May 18
Correspondence with SEC
12:00am
Gibson, Dunn & Crutcher LLP
555 Mission Street
San Franciso, CA 94105-0921
Tel 415.393.8200
www.gibsondunn.com
Client: 05637-00008
May 3, 2018
8-K
EX-99.1
c36kl6ivvg1y
15 Jan 15
Regulation FD Disclosure
12:00am
8-K
EX-99.1
rqwy4 5owse7x
12 Mar 24
Atossa Therapeutics Appoints Breast Cancer Specialist Tessa Cigler, M.D., M.P.H. to its Board of Directors
8:30am
8-K
EX-99.2
dc36t9sm d9
13 Sep 18
Atossa Genetics Announces Preliminary Results from
12:00am
S-3MEF
3p2zitdx78gfq uh
22 Mar 21
Registration of additional securities for an S-3
7:30am
8-K
EX-10.2
xdoc03udgtou7626s
10 Jun 15
Entry into a Material Definitive Agreement
12:00am
8-K
EX-4.1
wfp2v
10 Jun 15
Entry into a Material Definitive Agreement
12:00am
8-K
EX-4.1
aicalvm0
31 May 18
Material Modifications to Rights of Security Holders
6:33am